Amgen (AMGN) Tops Q2 EPS by 26c, Offers Guidance
Get Alerts AMGN Hot Sheet
Price: $269.38 -1.33%
Revenue Growth %: +22.5%
Financial Fact:
Total revenues: 5.81B
Today's EPS Names:
FRSB, DGICA, UXIN, More
Revenue Growth %: +22.5%
Financial Fact:
Total revenues: 5.81B
Today's EPS Names:
FRSB, DGICA, UXIN, More
Join SI Premium – FREE
Amgen (NASDAQ: AMGN) reported Q2 EPS of $4.65, $0.26 better than the analyst estimate of $4.39. Revenue for the quarter came in at $6.59 billion versus the consensus estimate of $6.53 billion.
GUIDANCE:
Amgen sees FY2022 EPS of $17.00-$18.00, versus the consensus of $17.40. Amgen sees FY2022 revenue of $25.5-26.4 billion, versus the consensus of $26.23 billion.
For earnings history and earnings-related data on Amgen (AMGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gilead Sciences (GILD) Misses Q1 EPS by 288c
- The First Of Long Island (FLIC) Misses Q1 EPS by 3c
- USCB Financial Holdings, Inc. (USCB) Tops Q1 EPS by 2c
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!